Evidence map›Paper›PMID 19653135›Full record

ReviewClinical reviews in allergy & immunology2010

X chromosome inactivation and autoimmunity.

Wesley H Brooks

Abstract readReview
PubMed Publisher
In one paragraph

Review in Clinical reviews in allergy & immunology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 77 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Sex differences in disease: sex chromosome and immunity.Journal of translational medicine · 2024
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Gender and genetic factors impacting COVID-19 severity.Journal of family medicine and primary care · 2021
    Review
  12. What microRNAs could tell us about the human X chromosome.Cellular and molecular life sciences : CMLS · 2020
    Review
  13. Review
  14. Autoimmunity in women: an eXClinical immunology (Orlando, Fla.) · 2020
    Review
  15. X-tra X: An escape to autoimmunity.The Journal of clinical investigation · 2019
    Article
  16. Review
  17. Review
  18. Article
  19. Epigenetic involvement in etiopathogenesis and implications in treatment of systemic lupus erythematous.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2017
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Wesley H BrooksExperimental HTS, Drug Discovery, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612-9416, USA. wesley.brooks@moffitt.org
Moffitt Cancer Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autoimmune diseases appear to have multiple contributing factors including genetics, epigenetics, environmental factors, and aging. The predominance of females among patients with autoimmune diseases suggests possible involvement of the X chromosome and X chromosome inactivation. X chromosome inactivation is an epigenetic event resulting in multiple levels of control for modulation of the expression of X-linked genes in normal female cells such that there remains only one active X chromosome in the cell. The extent of this control is unique among the chromosomes and has the potential for problems when regulation is disrupted. Here we discuss the X chromosome inactivation process and how the X chromosome and X chromosome inactivation may be involved in development of autoimmune disorders.

Indexed as

Chromosomes, Human, XX Chromosome InactivationAnimalsAutoimmune DiseasesDisease SusceptibilityDNA MethylationFemaleGene SilencingGranulomatous Disease, ChronicHumansHydrolasesProtein-Arginine Deiminase Type 4Sex Chromosome DisordersSex FactorsSignal TransductionSpermineHydrolasesProtein-Arginine Deiminase Type 4Spermine

Identifiers

PMID19653135
OpenAlexW2087597892

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.